NKGen Biotech shares are trading higher after the company announced FDA clearance of the IND application for SNK01 NK cell therapy in Parkinson's Disease.

NKGen Biotech Inc Ordinary Shares -7.75%

NKGen Biotech Inc Ordinary Shares

NKGN

1.19

-7.75%

NKGen Biotech shares are trading higher after the company announced FDA clearance of the IND application for SNK01 NK cell therapy in Parkinson's Disease.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via